Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3

Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. Kaczmarski, Ian Gabriel, Heather E. Oakervee, Martin F. Kaiser, Ashutosh Wechalekar, Reuben Benjamin, Jane F. Apperley, Holger W. Auner, Guido Franzoso

Open source

DOI
10.1016/j.toxrep.2019.04.006
Published
2019
Container
Toxicology Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.toxrep.2019.04.006,
  title = {Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3},
  author = {Laura Tornatore and Daria Capece and Daniel D'Andrea and Federica Begalli and Daniela Verzella and Jason Bennett and Gary Acton and Elizabeth A. Campbell and James Kelly and Michael Tarbit and Nigel Adams and Selina Bannoo and Antonio Leonardi and Annamaria Sandomenico and Domenico Raimondo and Menotti Ruvo and Angela Chambery and Metod Oblak and Magda J. Al-Obaidi and Richard S. Kaczmarski and Ian Gabriel and Heather E. Oakervee and Martin F. Kaiser and Ashutosh Wechalekar and Reuben Benjamin and Jane F. Apperley and Holger W. Auner and Guido Franzoso},
  year = {2019},
  journal = {Toxicology Reports},
  doi = {10.1016/j.toxrep.2019.04.006},
  url = {https://doi.org/10.1016/j.toxrep.2019.04.006}
}

RIS

TY  - JOUR
TI  - Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
AU  - Laura Tornatore
AU  - Daria Capece
AU  - Daniel D'Andrea
AU  - Federica Begalli
AU  - Daniela Verzella
AU  - Jason Bennett
AU  - Gary Acton
AU  - Elizabeth A. Campbell
AU  - James Kelly
AU  - Michael Tarbit
AU  - Nigel Adams
AU  - Selina Bannoo
AU  - Antonio Leonardi
AU  - Annamaria Sandomenico
AU  - Domenico Raimondo
AU  - Menotti Ruvo
AU  - Angela Chambery
AU  - Metod Oblak
AU  - Magda J. Al-Obaidi
AU  - Richard S. Kaczmarski
AU  - Ian Gabriel
AU  - Heather E. Oakervee
AU  - Martin F. Kaiser
AU  - Ashutosh Wechalekar
AU  - Reuben Benjamin
AU  - Jane F. Apperley
AU  - Holger W. Auner
AU  - Guido Franzoso
PY  - 2019
JO  - Toxicology Reports
DO  - 10.1016/j.toxrep.2019.04.006
UR  - https://doi.org/10.1016/j.toxrep.2019.04.006
ER  - 

APA

Tornatore, L., Capece, D., D'Andrea, D., Begalli, F., Verzella, D., Bennett, J., Acton, G., Campbell, E. A., Kelly, J., Tarbit, M., Adams, N., Bannoo, S., Leonardi, A., Sandomenico, A., Raimondo, D., Ruvo, M., Chambery, A., Oblak, M., Al-Obaidi, M. J., Kaczmarski, R. S., Gabriel, I., Oakervee, H. E., Kaiser, M. F., Wechalekar, A., Benjamin, R., Apperley, J. F., Auner, H. W., & Franzoso, G. (2019). Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3. Toxicology Reports. https://doi.org/10.1016/j.toxrep.2019.04.006

Source records